Signal / reference entry
Bremelanotide
Also listed as Vyleesi
Start with the scope. Follow the sources. Use the reading note to examine how a claim is supported.
Reference fields
View sourcesApproval labels are specific to a product, route, and use. Read the scope and limitations together.
- Status for this entry
- Approved product
- Evidence label
- Randomized evidence
Status as of
- Product and use
- Vyleesi: eligible premenopausal women with distressing acquired generalized low-desire disorder.
- Route context
- Subcutaneous injection.
- Mechanism
- Melanocortin-receptor agonist.
- Evidence
- Randomized trials.
- Limitations
- Exclude medical, relationship and drug causes; not performance enhancement.
- Safety
- Uncontrolled hypertension or known cardiovascular disease: contraindicated.
Read beyond the claim
A closer reading
When a paragraph combines a result with an explanation, mark the point where description becomes interpretation. Ask which words describe a measurement and which propose what that measurement means. If an explanation adds a claim about cause or importance, look for the reasoning that connects it to the reported observations. You do not have to reject interpretation to inspect that connection. Keeping the two parts visible lets you ask a sharper question: would the reported result still stand if you disagreed with the explanation attached to it?
Questions to take to the source
- Which part of this paragraph reports observations, and which part interprets them?
- What reasoning connects the stated result to the explanation offered here?
- Would the same observations remain relevant under a different plausible explanation?
Filed under
- Sexual health
Topics organize the index; they do not describe a recommended use.
Sources
These references support the reference fields as a group. Follow each link to inspect its scope and wording.
- VYLEESI NLM · Checked
- Kingsberg trials PubMed · Checked
Educational reference material. No clinician review is claimed. This entry does not provide personal medical advice.